Cisplatin treatment induced interleukin 6 and 8 production alters lung adenocarcinoma cell migration in an oncogenic mutation dependent manner

BACKGROUND: The predominant metastatic site of lung cancer (LC) is the brain. Although outdated, conventional cisplatin treatment is still the main therapeutic approach for patients with advanced non-small cell lung cancer (NSCLC), since targeted therapy that offers better tumor control is not alway...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiss, Edit, Abdelwahab, El Husseiny Mohamed Mahmud, Steib, Anita, Papp, Emoke, Torok, Zsofia, Jakab, Laszlo, Smuk, Gabor, Sarosi, Veronika, Pongracz, Judit Erzsebet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238555/
https://www.ncbi.nlm.nih.gov/pubmed/32434541
http://dx.doi.org/10.1186/s12931-020-01389-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238555/
https://www.ncbi.nlm.nih.gov/pubmed/32434541
http://dx.doi.org/10.1186/s12931-020-01389-x

Ejemplares similares